Predict your next investment

Inthera Bioscience company logo
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
intherabio.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$14.8M

Last Raised

$11.1M | 4 yrs ago

About Inthera Bioscience

Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible signaling for the treatment of solid tumors and targeted agents against HPV- associated cancer, which are in pre-clinical development. Inthera Bioscience is a biopharmaceutical company focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform.

Inthera Bioscience Headquarter Location

Einsiedlerstrasse 34

Waedenswil, 8820,

Switzerland

Latest Inthera Bioscience News

Inthera binds funding to series A round

Jul 2, 2018

Inthera binds funding to series A round The cancer therapy developer has closed an $11.1m series A round featuring M Ventures and seed-stage backer Novo Seeds. Author: Callum Cyrus, Reporter Switzerland-based oncology therapy developer Inthera Bioscience has closed a series A round featuring subsidiaries of pharmaceutical firms Merck & Co and Novo at €9.6m ($11.1m). This rest of this content is only accessible to Global Corporate Venturing Subscribers This content is only accessible to subscribers. If you are a subscriber,please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Inthera Bioscience

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Inthera Bioscience is included in 4 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

D

Digital Health

11,220 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

Inthera Bioscience Patents

Inthera Bioscience has filed 2 patents.

The 3 most popular patent topics include:

  • Sedatives
  • Stereochemistry
  • Hypnotics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/17/2018

7/14/2020

Small nuclear RNA, V8SuperTourer drivers, Stereochemistry, Trifluoromethyl compounds, Sedatives

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/17/2018

00/00/0000

Grant Date

7/14/2020

00/00/0000

Title

Subscribe to see more

Related Topics

Small nuclear RNA, V8SuperTourer drivers, Stereochemistry, Trifluoromethyl compounds, Sedatives

Subscribe to see more

Status

Grant

Subscribe to see more

Inthera Bioscience Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Inthera Bioscience Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.